Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. a single-institution phase study

British Journal of Urology

Volumn 80, Issue 1, 1997, Pages 44-49

  Fellin, G ^a  

^a SANTA CHIARA HOSPITAL   (Italy)

Author keywords

Bladder carcinoma; Bladder preservation; Chemotherapy; Combined modality; Radiotherapy

Indexed keywords

CISPLATIN; METHOTREXATE; VINBLASTINE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER INVASION; CANCER RECURRENCE; CLINICAL TRIAL; CYSTECTOMY; CYSTOSCOPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE CANCER; ORGAN PRESERVATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 0031400538     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Skinner DG, Lieskovsky G. Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in the management of invasive bladder cancer. J Urol 1984; 131: 1069-72
2. Quilty PM, Duncan W. Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control. Int J Radiat Oncol Biol Phys 1986: 12: 853-60
3. Pollach A, Zagars GK, Swanson DA. Muscle invasive bladder cancer treated with external beam radiotherapy: prognostic factors. Int JRadiat Oncol Biol Phys 1994; 30: 267-77
4. Sternberg CN, Yagoda A, Scher HI et al. M-VAC (methotrexate, vinblastine. doxorubicine and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol 1988; 139:461-9
5. Jeffery GM, Mead GM. CMV chemotherapy for advanced transitional cell carcinoma. Br JCancer 1992; 66: 542-6
6. Skinner DG, Daniels JR. Russel CA et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 1991; 145: 459-67
7. Malmstrom P, Rintale E, Walqvist R et al Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: nordic cystectomy Trial I. J Urol 1996; 155: 1903-6
8. Tester W. Porter A. Asbell S et al. Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12. Int ] Radiat Oncol Biol Phys 1993; 25: 783-90
9. Housset M, Maulard C, Chretien YC et al Combined radiation and chemotherapy for invasive transitional cell cancer of the bladder: a prospective study. J Clin Oncol 1993; 11: 2150-7
10. Dunst I. Sauer R, Schrott KM. Kuhn R, Wittekind C, Anteldorf-Hofmann A. Organ sparing treatment of advanced bladder cancer: a 10 year experience. Int JRadial Oncol Biol Phys 1994: 30: 261-6
11. Cervek J, Cufer T. Kragely B. Zakotnik B, Stanomik M. Sequential transurethral surgery, multiple drug chemotherapy and radiation therapy for invasive bladder carcinoma: initial report. lut J Radiat Oncol Biol Phys 1993; 25: 777-82
12. Kaufman DS, Shipley WU, Griffin PP, Heney NM, Althausen AF, Eflrd JT. Selective preservation by combination treatment of invasive bladder cancer. N Engl JMed 1993; 329: 1377-82
13. Tester W, Caplan R, Heaney J et al. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase trial 8802. ; Clin Oncol 1996; 14: 119-26
14. Fellin G, Graffer U, Bolner A, Luciani L. Transurethral resection and definitive Radiotherapy for carcinoma of the bladder. Acta Urol liai 1996; 10: 1-5
15. Zietman AL, Shipley WU, Kaufman DS. The combination of cisplatin based chemotherapy and radiation in the treatment of muscle invading transitional cell cancer of the bladder. Int J Radiat Oncol Biol Phys 1993; 27: 161-70
16. Zietman AL, Shipley WU. Organ sparing treatment for bladder cancer: time to beat the drum. Int J Radiat Oncol Biol Phys 1994; 30: 741-2
17. Sullivan LD, Coppin CC, Gospodarowicz M et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. Proc AUA 91st, JUrol 1996; 166: 666 (Abstr. 1422)
18. Kachnik LA, Kaufman DS, Zietman AL et al. Selective bladder preservation by combined modality therapy for invasive bladder cancer. Proc ASTRO 37th, Int J Radiât Oncol Biol Phys 1995; 32: SI. 271 (Abstr 2018)
19. Caffo 0. Fellin G, Graffer U. Luciani L. Assessment of quality of life after cystectomy or conservative therapy for infiltrating bladder cancer: survey by a self administered questionnaire. Cancer 1996; 78: 1089-97
20. Hall RR. Neoadjuvant CMV chemotherapy and cystectomy or radiotherapy in muscle invasive bladder cancer. First analysis of MRC/EORTC intercontinental trial. Proc ASCO 32nd. J Clin Oncol 1996; 15: 244 (Abstr 612)